Introduction
============

The radiological appearance of the breast on mammography varies greatly among women because of the different X-ray attenuation characteristics of fat, and epithelial and stromal components that comprise the breast tissue \[[@B1],[@B2]\]. A method of classifying these variations was described by Wolfe in 1976 \[[@B3]\], and extensive mammographic density is now recognized to be one of the most important risk factors for human breast cancer \[[@B4]-[@B13]\]. Women with mammographic density in more than 75% of breast tissue are at four to six times higher risk for developing breast cancer than those with little or no density \[[@B5],[@B10],[@B14]\]. Although the elements that constitute mammographic density are poorly understood at present, there is evidence that stromal and epithelial cells, as well as collagen, contribute toward density in human mammographic images \[[@B15]-[@B17]\].

Disease modelling in mice has become a powerful tool for investigating the physiological and genetic factors that are involved in human disease. It is not known whether mammary gland density is a risk factor in mice because a suitable mouse model in which to study mammary density is currently lacking. As a necessary first step toward the eventual goal of developing such a mouse model, here we asked whether mammographic density could be altered within the mouse mammary gland. In particular, we designed our study to evaluate whether experimental manipulation of individual compartments, namely the stromal cells, matrix, or epithelium, leads to altered radiological mammographic density. We also took a genetic approach to address the correlation between epithelial structure and mammographic density using genetically engineered mouse mutants.

Methods
=======

The fourth inguinal mammary glands were selected for the study because they contain a centrally located lymph node that can guide the site of inoculation, and because they have been widely studied \[[@B18]-[@B20]\]. Injections were always performed frontal to the lymph node. The contralateral inguinal mammary gland in each mouse was used as the sham control. Inoculations included a 40 μl volume of either Matrigel (Becton Dickinson, Mississauga, Ontario, Canada) or cell media containing 5 × 10^6^Swiss 3T3 fibroblasts. Mammary glands following experimental manipulations or sham (surgery followed by the needle insertion) were isolated 5 days later. For *ex vivo*imaging studies, each gland was successively subjected to the following regimen: immediate radiography using Faxitron Specimen Radiography System (Model MX-20; 5 s exposure time at 18 kV; Faxitron X-Ray Corp., Wheeling, Illinois, USA) on the tissue placed in a plastic petri dish; whole mount carmine alum staining upon mounting the tissue on a glass slide using standard protocols \[[@B19]\]; and histology following tissue fixation and paraffin embedding.

For *in vivo*imaging studies, 5 days after experimental manipulations x-ray images of anaesthetized mice were taken using Faxitron Specimen Radiography System (Model MX-20; 10 s exposure time at 24 kV). The uninjected contralateral glands served as controls. Mammary glands were positioned flat using 25 G needles. Mammary glands were then Isolated and imaged *ex vivo*.

All purchased mice were females from The Jackson Laboratory (Bar Harbor, Maine, USA). Strains used were: a) FVB/N, and b) BALB/c *Foxn1*^*nu*^/*Foxn1*^*nu*^nude mice, c) MMTV-PyMT transgenic on FVB/N background, and d) *Pten*-deficient mice were in a mixed background of C57BL/6 and 129SvEvTac strain, in these mice inactivation of *Pten*has been achieved in several organs including breast using the Cre-*loxP*system (*Pten*^*loxP*/*loxP*^; *Mmtv-cre*mice) \[[@B21],[@B22]\]. The epithelial ductal tree is severely stunted in these mice and serves as a model of epithelial hypoplasia. The animals were cared for in accordance with the guidelines established by the Canadian Council on Animal Care.

Results and discussion
======================

As illustrated, sham treated mammary glands produced a homogeneous radiological image (Fig. [1a](#F1){ref-type="fig"}), and the mammary whole mount (Fig. [1b](#F1){ref-type="fig"}) indicated little intragland variation. Histology showed an epithelial ductal tree emanating from the teat region (arrowhead), spanning the mammary fat pad (Fig. [1c](#F1){ref-type="fig"}) and embedded within the adipose compartment (arrowheads in Fig. [1d](#F1){ref-type="fig"}). Trichrome-stained tissue (Fig. [1e](#F1){ref-type="fig"}) showed ductal epithelium composed of a single layer of epithelial cells (arrowhead) surrounded by stromal fibroblasts (arrow) that lay within the extracellular matrix (blue staining). Next, we undertook to alter these specific components of the mammary tissue.

Matrigel, which is basement membrane matrix derived from Engelbreth-Holm-Swarm mouse sarcoma, and is composed mostly of laminin, collagen type IV, heparan sulphate proteoglycans, entactin and nidogen, was administered to produce local matrix deposition. When examined 5 days later by radiology, the Matrigel injected site was evident as a pronounced radiologically dense area (arrowheads in Fig. [1f](#F1){ref-type="fig"}), which was also apparent in the whole mount (arrowheads in Fig. [1g](#F1){ref-type="fig"}). Trichrome staining of mammary tissue sections confirmed the presence of collagens embedded within the mammary fat pad at this particular location (arrowheads in Fig. [1h](#F1){ref-type="fig"}). Higher magnification images showed collagen surrounding clusters of cells (Fig. [1i,1j](#F1){ref-type="fig"}).

Next, we reasoned that fibroblasts would provide a means of increasing the stromal cell component of the mammary gland. Figure [1k](#F1){ref-type="fig"} shows the radiological image following an inoculation of Swiss 3T3 fibroblasts. A highly dense pocket was evident in the mammographic radiograph (arrowheads), and a cellular mass could be seen frontal to the lymph node in the whole mount (Fig. [1l](#F1){ref-type="fig"}) and histology (Fig. [1m](#F1){ref-type="fig"}), as highlighted by the arrowheads. Fibroblasts (arrowheads) were the major cellular component of this mass, with some infiltration by polymorphonuclear cells (arrows) that probably represented a limited inflammatory response (Fig. [1n,1o](#F1){ref-type="fig"}).

Finally, for manipulation of the epithelial compartment, mammary glands were taken from pregnant mice at day 13 of gestation. During pregnancy, alveolar epithelial cells proliferate and differentiate to become secretory alveoli in preparation for lactation, replacing much of the adipose compartment such that the mammary gland is primarily comprised of epithelial structures \[[@B23]-[@B25]\]. Radiology revealed a smattering of density dispersed throughout the gland, with most densities nearest to the lymph node, and gradually fading toward the edges of the gland (Fig. [1p](#F1){ref-type="fig"}). This density mirrored the epithelial ductal tree at the whole mount level (Fig. [1q](#F1){ref-type="fig"}), and an abundance of lobuloalveoli was evident at the cellular level (Fig. [1r,1s,1t](#F1){ref-type="fig"}). All of the above observations were reproduced in at least three independent experiments.

Having found that expanded epithelial structures formed during gestation correlated with increased mammographic density, we next examined whether mammary gland with hypoplastic epithelium would exhibit reduced radiographic density. Seven-week-old *Pten*conditional knockout mice, which have severely attenuated ductal epithelium (Fig. [2f,2g,2h,2i,2j](#F2){ref-type="fig"}), and their age-matched wild-type littermates (Fig. [2a,2b,2c,2d,2e](#F2){ref-type="fig"}) were examined. At this age, the epithelial ductal tree typically grows past the lymph node in wild-type mice, covering two-thirds of the mammary fat pad (Fig. [2b](#F2){ref-type="fig"}). A reduction in density was noticeable in the mouse mammographic images of *Pten*-deficient mice as compared with control animals (Fig. [2f](#F2){ref-type="fig"} versus Fig. [2a](#F2){ref-type="fig"}). Whole mounts (Fig. [2g](#F2){ref-type="fig"} versus Fig. [2b](#F2){ref-type="fig"}) and histology (Fig. [2h](#F2){ref-type="fig"} versus Fig. [2c](#F2){ref-type="fig"}) of *Pten*-deficient mice exhibited an absence of epithelial and stromal structures. Lymphomas are prevalent in these mutant animals by 6 weeks of age \[[@B22]\], and are noticeable in Fig. [2](#F2){ref-type="fig"}.

Next we generated and imaged mammographic density in intact mammary glands *in vivo*. In order to avoid any potential interference from the hair coat on radiographic imaging, we chose to use nude mice in our initial *in vivo*experiments. Radiographic imaging was performed 5 days after injection of either matrigel or fibroblasts, or at day 14 of gestation (Fig. [3c,3d,3e,3f,3g,3h](#F3){ref-type="fig"}). Mice were anaesthetized, and the fourth mammary gland was flattened by pinning. Figure [3a](#F3){ref-type="fig"} and [3b](#F3){ref-type="fig"} show a representative unmanipulated mammary gland with homogeneous radiographic density. The margins of the mammary gland are demarcated by yellow dotted lines, and the lymph nodes are indicated. Injected cells and matrigel created a region of density (arrowheads) distinguishable from the surrounding normal gland (Fig. [3c,3f](#F3){ref-type="fig"}). Such regions were not present in any of the untreated contralateral glands, which served as controls for each mouse (Fig. [3a,3b](#F3){ref-type="fig"}). Increased density was also apparent in the mammary gland of a mouse at day 14 of gestation, but was less well demarcated because of its diffuse nature (Fig. [3g,3h](#F3){ref-type="fig"}). *Ex vivo*radiography of all of these glands confirmed the presence of density observed *in vivo*(Fig. [3b,3d,3f,3h,3j](#F3){ref-type="fig"}).

Using a well established mammary tumor model, the MMTV-PyMT mouse, we next imaged the hyperplastic and tumor bearing mammary gland by radiography in an intact 80-day-old mouse. Figure [3i](#F3){ref-type="fig"} and [3j](#F3){ref-type="fig"} illustrate the highly increased *in vivo*and *ex vivo*radiographic density that results from mammary tumor formation.

Conclusion
==========

This study establishes the mouse as a model for mammographic density research and demonstrates the feasibility of mouse mammographic imaging. Here we show for the first time that mouse mammography can be carried out *in vivo*. Furthermore, we demonstrate that mammographic density can be experimentally induced and imaged in a live mouse. Areas of density were generated experimentally through individual manipulation of stromal fibroblasts, epithelium, or matrix, which produced qualitatively distinct mammographic images both *in vivo*and *ex vivo*. Furthermore, *Pten*-deficient mice and MMTV-PyMT transgenic mice served as genetic models in which to investigate whether the inherent structure of mammary gland correlates with mammographic density. The hypoplastic epithelium in *Pten*-deficient mice resulted in glands with low mammographic density and, conversely, hyperplastic glands of MMTV-PyMT exhibited pronounced radiographic density.

This new line of research faces many challenges. One of these is the need to maintain experimentally generated mammographic density over a time period that is sufficiently prolonged to allow development of the pathophysiological changes that lead to mammary cancer in mice. Comparisons between highly dense and less dense mammary glands may reveal differences in their susceptibility to mammary tumor formation. There is also a need to quantify and standardize mouse mammograms accurately, using means such as those developed for human mammography \[[@B26]-[@B28]\]. This will allow research on mammographic density using genetic mouse models that have either a loss-of-function or gain-of-function of genes linked to breast cancer. Specifically, it will help us to explore the relationship between genetic changes, mammographic density and breast cancer susceptibility. This work forms the basis for exploiting the mouse as a model in which to study mammographic density.
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![Generation of mammographic densities in the mouse mammary gland. Panels **a--e**represent a mammary gland from sham treated mice, **f--j**illustrate Matrigel injected mammary glands, **k--o**show fibroblast inoculated mammary gland, and **p--t**show a mammary gland from a pregnant mouse at day 13 of gestation. Each set of glands was successively analyzed by radiography (panels a, f, k and p), carmine alum whole mount staining (panels b, g, l and q), and trichrome staining (panels c--e, h--j and m--o) or haematoxylin and eosin staining (panels r--t). The size bar in panel c is 2 mm, and this magnification also applies to panels a, b, f--h, k--m and p--r. The size bar in panel d is 0.2 mm (which also applies to panels i and n); in panel e it is 20 μm; in panel j it is 0.04 mm (which also applies to panel t); in panel o it is 10 μm; and in panel s it is 1 mm. LN, lymph node.](bcr901-1){#F1}

![Mouse mammographic images of *Pten*^*loxP*/*loxP*^; *Mmtv-cre*mice. **(a--e)**Wild-type littermates or **(f--j)**mammary gland-specific *pten*deficient mice were successively subjected to radiography (panels a and f), carmine alum whole mount staining (panels b and g) and haematoxylin and eosin staining (panels c and h). Higher magnification of the mammary tissue (panels d, e, I and j) are shown. The size bar in panel c is 2 mm, and this magnification also applies to panels a, b and f--h. The size bar in panel d is 1 mm; in panel e it is 0.2 mm (which also applies to panel i); and in panel j it is 0.04 mm. LN, lymph node.](bcr901-2){#F2}

![*In vivo*and *ex vivo*images of normal and altered mammographic density. Panels **a**, **c**, **e**, **g**and **i**are mammographic images from live mice, and panels **b**, **d**, **f**, **h**and **j**are the same glands imaged *ex vivo*. Mice were treated as follows: panels a and b, untreated mouse; panels c and d, mammary gland inoculated with fibroblasts; panels e and f, mammary gland injected with matrigel; and panels g and h, day 14 of gestation. Panels I and j are from an MMTV-PyMT mouse with multiple mammary tumors. The size bar in all panels is 5 mm. LN, lymph node.](bcr901-3){#F3}
